Daniel R. Passeri, CEO and President at Cue Biopharma, Inc. (CUE), bought 1,377 shares at $7.26 ($10K) on 2019-06-21, disclosed to the SEC on 2019-06-25.
Open-market purchase of $10k CUE by CEO and President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CUE | BUY | 2021-09-27 | $50K | — | Filing → |
| CUE | BUY | 2019-06-07 | $21K | — | Filing → |
| CUE | BUY | 2018-08-20 | $49K | — | Filing → |